BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lv YY, Shi BY, Guo H. Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B. World J Gastroenterol 2008; 14(29): 4713-4715 [PMID: 18698691 DOI: 10.3748/wjg.14.4713]
URL: https://www.wjgnet.com/1007-9327/full/v14/i29/4713.htm
Number Citing Articles
1
Young Kwang Chae, Lauren Chiec, Nisha Mohindra, Ryan Gentzler, Jyoti Patel, Francis Giles. A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetesCancer Immunology, Immunotherapy 2017; 66(1): 25 doi: 10.1007/s00262-016-1913-7
2
Yun Nah Lee, Soung Won Jeong, Jae Hee Lim, Yang Seon Ryu, Seong Ran Jeon, Sang Kyun Kim, Jae Young Jang, Young Seok Kim, Boo Sung Kim, Mi Oh Roh. Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis CThe Korean Journal of Hepatology 2010; 16(2): 187 doi: 10.3350/kjhep.2010.16.2.187
3
Runia F. El-Folly, Maram M. Maher M., Ayman R. Abdelkader. Thyroid dysfunction in chronic viral hepatitis [B and C]; An Egyptian pilot studyEgyptian Liver Journal 2016; 6(4): 70 doi: 10.1097/01.ELX.0000520136.24876.3e
4
Linghuan Wang, Kang Chen, Meirong Wang, Zhaohui Lv, Weijun Gu, Xianling Wang, Qi Ni, Yiming Mu. Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A ReviewHormone and Metabolic Research 2022; 54(03): 145 doi: 10.1055/a-1749-5716
5
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1889628
6
Irene Vinagre, Mercedes Rigla, Xavier Torras, Jaime Enríquez, Rosa Corcoy. Aparición de diabetes mellitus tipo 1 durante el tratamiento con interferón alfa: dos casos clínicosEndocrinología y Nutrición 2010; 57(8): 393 doi: 10.1016/j.endonu.2010.03.016